Ancero, Calaudio .
HRN: 01 01 09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/30/2022
10/07/2022
IV
500mg
Q6
Amoebiasis, AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes